SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001599298-24-000056
Filing Date
2024-04-04
Accepted
2024-04-04 17:43:05
Documents
1
Period of Report
2024-04-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1712266971.html 3  
1 FORM 3 wk-form3_1712266971.xml 3 2229
  Complete submission text file 0001599298-24-000056.txt   3851
Mailing Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025
Business Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025 650-460-8308
Summit Therapeutics Inc. (Issuer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 5320 LEGACY DRIVE PLANO TX 75024
Business Address
Anand Bhaskar (Reporting) CIK: 0001890784 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36866 | Film No.: 24824190